Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations

Annals of Thoracic Surgery

Volumn 61, Issue 2, 1996, Pages 651-656

  Wang, Ming Jiuh ^a   Chiu, Ing Sh ^a   Hsu, Chao Ming ^a   Wang, Chao Min ^a   Lin, Pei Lin ^a   Chang, Chung I ^a   Huang, Chi Hsiang ^a   Chu, Shu Hsun ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; LEUKOCYTE ELASTASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 0030046942     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)00974-4     Document Type: Article

References (16)

1. Maehara T, Novak I, Wyse RKH, Elliott MJ. Perioperative monitoring of total body water by bioelectrical impedance in children undergoing open heart surgery. Eur J Cardiothorac Surg 1991;5:258-65.
2. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993;105:25-30.
3. Finn A, Naik S, Klein N, Levinsky RJ, Strobel S, Elliott M. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
4. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993;40:1016-21.
5. Roumen R, Redl H, Schlag G, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995;23: 474-80.
6. Donnelly S, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:1428-33.
7. Hashimoto K, Miyamoto H, Suzuki K, et al. Evidence of organ damage after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;104:666-73.
8. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon J. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
9. Naik S, Knight A, Elliott MJ. A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991;84(Suppl 3): 422-31.
10. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 1994;81:1181-9.
11. Millar AB, Armstrong L, van der Linden J, et al. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993;56:1499-502.
12. Andreasson S, Gothberg S, Berggren H, Bengtsson A, Eriksson E, Risberg B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993;56:1515-7.
13. Naik S, Elliott MJ. Ultrafiltration. In: Jonas RA, Elliott MJ, eds. Cardiopulmonary bypass in neonates, infants and young children. 1st ed. Oxford: Butterworth-Heinemann, 1994:150-72.
14. Moore RA, Laub GW. Hemofiltration, dialysis, and blood salvage techniques during cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR, eds. Cardiopulmonary bypass: principles and practice. 1st ed. Baltimore: Williams & Wilkins, 1994:93-123.
15. Matsushima K, Morishita K, Yoshimura T, et al. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 1988;167: 1883-93.
16. Weissenbach J, Chernajovsky Y, Zeevi M, et al. Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 1980;77:7152-6.